Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection

Review of global use of licensed vaccines and development of new vaccines for the prevention of pneumococcal infection

Streptococcus pneumoniae infection is the most common cause of high morbidity and mortality among children under 5 years of age, immunocompromised people, and the elderly. Despite significant success, the approved pneumococcal conjugate and polysaccharide vaccines are of limited efficacy, providing...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Savkina, M. A. Krivykh, N. A. Gavrilova, L. V. Sayapina, Yu. I. Obukhov, V. A. Merkulov, V. P. Bondarev
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2021-12-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
<i>streptococcus pneumonia</i>
conjugate vaccines
polysaccharide vaccines
whole-cell vaccines
protein-based pneumococcal vaccines
pneumococcal vaccines with an antigen delivery system
Online Access:https://www.biopreparations.ru/jour/article/view/350
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.biopreparations.ru/jour/article/view/350

Similar Items